Status:
COMPLETED
Improving Safety of Antivenom in People Bitten by Snakes
Lead Sponsor:
University of Kelaniya
Conditions:
Snake Bites
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, \& hydrocortisone (alone and in combination) to prevent acute advers...
Eligibility Criteria
Inclusion
- Above 12 years of age
- Patients admitted to hospital after snake bite in whom antivenom is indicated
- Patients who give informed consent
Exclusion
- Patients who are pregnant or nursing
- Patients who are currently taking beta- or alpha-adrenoceptor antagonists, or tricyclic antidepressants
- Patients in whom adrenaline may be contraindicated (this may include patients with the following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and tachyarrhythmias)
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00270777
Start Date
March 1 2005
End Date
April 1 2008
Last Update
June 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trials Unit, University of Kelaniya
Ragama, Sri Lanka